Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA) , supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
De Hert, M.; Dekker, J.M.; Wood, D.; Kahl, K.G.; Holt, R.I.G.; Möller, H-J.
European psychiatry the journal of the Association of European Psychiatrists 24(6): 412-424
2009
ISSN/ISBN: 0924-9338 PMID: 19682863 DOI: 10.1016/j.eurpsy.2009.01.005Document Number: 311656
People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension and dyslipidaemia. Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors. Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate cooperation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes.
Document emailed within 0-6 h
